UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF
THE SECURITIES AND EXCHANGE ACT OF 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): May 23, 2000
Commission file number 001-12055
PARACELSUS HEALTHCARE CORPORATION
(Exact name of registrant as specified in its charter)
CALIFORNIA 95-3565943
(State or other jurisdiction of (IRS Employer
incorporation or organization) Identification No.)
515 W. Greens Road, Suite 500, Houston, Texas
(Address of principal executive offices)
77067 (281) 774-5100
(Zip Code) (Registrant's telephone number,
including area code)
ITEM 5. OTHER EVENTS
On May 23, 2000, The New York Stock Exchange (the "Exchange")
informed Paracelsus Healthcare Corporation (the "Company") that the Exchange
decided to suspend further trading of the Company's common stock and plans to
apply to the Securities and Exchange Commission to delist the issue. Among the
reasons cited by the Exchange were that the trading price of the stock was
abnormally low and that the Company had fallen below certain of the Exchange's
continued listing criteria.
The Company is exploring alternative public trading markets for its
stock.
On May 23, 2000, the Company issued a press release on the above related
matter, a copy of which is included in Exhibit 99.3 to this Form 8-K and is
incorporated herein by reference.
Item 7. Financial Statements and Exhibits.
(c) Exhibits.
Exhibit 99.3 Press Release dated May 23, 2000 issued by the
Company.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Paracelsus Healthcare Corporation
(Registrant)
Dated: May 23, 2000 By: /S/ LAWRENCE A. HUMPHREY
----------------------------------
Lawrence A. Humphrey
Executive Vice President,
& Chief Financial Officer